Evolving personal work patterns are demonstrating people’s amazing adaptability in the face of the pandemic: people are becoming much more comfortable and efficient at using virtual meetings, European Biotech leaders reveal to Egon Zehnder in a recent digital gathering.
As Contract Development and Manufacturing Organizations (CDMOs) in the BioPharma space have boomed and broadened their capabilities in recent years, they have entered a more complex era that presents a host of new challenges.
As financial pressure on payers has increased, and evidence-based pricing moves up the agenda, market access has become one of the single biggest challenges pharmaceuticals companies face.
You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.